 |
| |
| May-17-18 | Resumed |
Piper Jaffray |
Overweight |
$77 |
|
| Feb-06-18 | Reiterated |
Citigroup |
Neutral |
$66 → $70 |
|
| Jan-03-18 | Upgrade |
Raymond James |
Mkt Perform → Outperform |
|
|
| Jan-03-18 | Initiated |
Evercore ISI |
Outperform |
|
|
| Jan-02-18 | Upgrade |
JP Morgan |
Neutral → Overweight |
|
|
| Jan-02-18 | Upgrade |
BofA/Merrill |
Neutral → Buy |
|
|
| Aug-17-17 | Initiated |
Citigroup |
Neutral |
$63 |
|
| Jul-28-17 | Reiterated |
UBS |
Neutral |
$57 → $62 |
|
| Jul-27-17 | Reiterated |
Barclays |
Overweight |
$64 → $70 |
|
| Jun-30-17 | Initiated |
Cantor Fitzgerald |
Overweight |
$70 |
|
| Apr-27-17 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$55 → $58 |
|
| Apr-04-17 | Upgrade |
Leerink Partners |
Mkt Perform → Outperform |
|
|
| Oct-26-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$50 → $55 |
|
| Oct-13-16 | Initiated |
Wells Fargo |
Outperform |
|
|
| Jul-27-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$47 → $50 |
|
| Jun-06-16 | Resumed |
JP Morgan |
Neutral |
|
|
| Apr-27-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$40 → $47 |
|
| Apr-14-16 | Upgrade |
Piper Jaffray |
Neutral → Overweight |
|
|
| Feb-03-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$37 → $40 |
|
| Nov-16-15 | Resumed |
Piper Jaffray |
Neutral |
$90 → $39 |
|
|
|
| Jun-18-18 07:32AM | Zacks.com highlights: Jazz Pharmaceuticals, Baxter International, Boise Cascade, Insight Enterprises and Comfort Systems USA Zacks |
| Jun-14-18 05:30PM | Baxter CEO on what's driving his company's stock price to... CNBC Videos |
| Jun-13-18 09:04AM | Baxter (BAX) Soars to a 52-Week High, Time to Cash Out? Zacks |
| Jun-08-18 10:02AM | Cooper Companies (COO) Q2 Earnings & Revenues Beat Estimates Zacks |
| Jun-05-18 07:55AM | Akers Biosciences and Three Additional Stocks Under Scanner in the Medical Supplies Space ACCESSWIRE |
| 01:10AM | You May Be Losing Money By Not Redlining Language Changes In 10-Ks Forbes |
| Jun-04-18 09:46AM | The Zacks Analyst Blog Highlights: Facebook, Intel, Boeing, Las Vegas Sands and Baxter Zacks |
| May-31-18 11:10AM | Here's Why You Should Invest in Baxter International Now Zacks |
| May-30-18 05:00PM | Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress That Further Demonstrate Value of HDx Therapy Enabled by THERANOVA Business Wire |
| 09:45AM | 5 Stocks Near 52-Week High With Potential to Scale Higher Zacks |
| 09:28AM | US-North Korea Summit Talks Resume: 4 MedTech Stocks to Watch Zacks |
| 07:43AM | Intuitive Surgical Commences Direct Operations in India Zacks |
| 06:30AM | Baxter Unveiled Updates to SHARESOURCE Remote Patient Management Platform for Home Dialysis Patients at ERA-EDTA 2018 Business Wire |
| 06:02AM | Baxter International Stock Is at an All-Time High: Is It a Buy? Motley Fool |
| May-29-18 02:52PM | Medical Device Stocks Could Be Gearing Up to Be Market Leaders TheStreet.com |
| 08:37AM | Trade War May Pull MedTech Down: 3 Stocks to Defy the Odds Zacks |
| May-28-18 08:22AM | Baxter International (BAX) Hits a 52-Week High, Can the Run Continue? Zacks |
| 03:09AM | Baxter International (BAX) Up 3.5% Since Earnings Report: Can It Continue? Zacks |
| May-24-18 01:41PM | Medtronic (MDT) Q4 Earnings Beat on Growth in All Lines Zacks |
| May-22-18 11:15AM | Baxter CEO Sees New Products, Expansion Driving Growth Bloomberg Video |
| 11:15AM | Baxter CEO Sees New Products, Expansion Driving Growth Bloomberg |
| May-21-18 08:00AM | Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference Business Wire |
| May-17-18 04:15PM | Baxter to Present at the Goldman Sachs Healthcare Conference Business Wire |
| May-15-18 05:38PM | Soros trims Liberty Broadband stake, adds Aetna, Baxter International shares MarketWatch |
| 04:15PM | Baxter to Host 2018 Investor Conference Business Wire |
| 10:04AM | Zacks.com highlights: Schweitzer-Mauduit International, Insight Enterprises, Baxter International, Fortinet and Comfort Systems USA Zacks |
| 09:35AM | Baxter (BAX) Gets FDA Nod for Spectrum IQ, Secures Infusions Zacks |
| 09:14AM | GNC Holdings' Global Prospects Solid, Competition Stiff Zacks |
| 09:11AM | CryoLife (CRY) Stock Gains 9.5% on Impressive Q1 Earnings Zacks |
| May-14-18 02:46PM | Orthofix (OFIX) Stock Declines 13% on '18 Earnings View Cut Zacks |
| 01:00PM | 5 Stocks Near 52-Week High With Scope to Perform Better InvestorPlace |
| 09:14AM | Chemed (CHE) Stock is Worth a Bet Right Now: Here's Why Zacks |
| 08:31AM | Baxter Announces U.S. FDA Clearance of New Spectrum IQ Infusion System Business Wire |
| May-11-18 09:11AM | BioScrip (BIOS) Q1 Loss Wider Than Expected, Revenues Beat Zacks |
| 08:39AM | Zacks.com featured highlights include: Marine Products, Nutrisystem, Exelixis, Illumina and Baxter Zacks |
| May-10-18 02:58PM | MARKETS: Biotech and pharma stocks could be the key to the market bull case Yahoo Finance Video |
| 09:12AM | STERIS (STE) Q4 Earnings & Revenues Beat Estimates, Up Y/Y Zacks |
| 08:54AM | Wright Medical (WMGI) Beats on Q1 Earnings, Keeps Guidance Zacks |
| 08:47AM | 5 Winning Stocks With Superb Efficiency Level Zacks |
| 08:38AM | Haemonetics (HAE) Q4 Earnings Meet, Revenues Beat Estimates Zacks |
| May-09-18 10:32AM | Penumbra (PEN) Q1 Earnings & Revenues Top Estimates, View Up Zacks |
| 10:03AM | Luminex (LMNX) Beats Q1 Estimates on ARIES Platform Strength Zacks |
| 09:34AM | Fresenius Medical (FMS) Misses on Q1 Earnings, Lowers View Zacks |
| 09:28AM | Myriad Genetics (MYGN) Beats on Earnings & Revenues in Q3 Zacks |
| 04:48AM | Henry Schein's (HSIC) Q1 Earnings Beat, '18 View Intact Zacks |
| May-08-18 11:34AM | Amedisys (AMED) Q1 Earnings, Revenues Beat on Overall Growth Zacks |
| 10:38AM | Phibro Animal (PAHC) Q3 Earnings Beat, Sales Improve Y/Y Zacks |
| 10:09AM | DaVita (DVA) Beats Q1 Earnings Estimates, Reiterates View Zacks |
| 09:47AM | PetMed (PETS) Q4 Earnings Top Estimates, Reorder Sales Solid Zacks |
| 09:09AM | Baxter boosts quarterly dividend by 19%, effective July MarketWatch |
| 09:00AM | Baxter Declares Dividend and Announces Quarterly Dividend Increase Business Wire |
| May-07-18 10:54AM | Bruker (BRKR) Q1 Earnings & Revenues Beat, Margins Expand Zacks |
| 10:07AM | ABIOMED (ABMD) Earnings Beat Estimates in Q4, View Impressive Zacks |
| 09:23AM | Surmodics (SRDX) Beats on Q2 Earnings & Revenues, Raises View Zacks |
| 08:59AM | DENTSPLY (XRAY) Beats Q1 Earnings Estimates, Lowers View Zacks |
| May-04-18 02:45PM | IDEXX Laboratories (IDXX) Earnings, Revenues Rise in Q1 Zacks |
| 02:40PM | QIAGEN (QGEN) Beats Earnings, Revenue Estimates in Q1 Zacks |
| 11:00AM | Masimo (MASI) Beats on Q1 Earnings, Raises '18 Guidance Zacks |
| 10:00AM | Integer Holdings (ITGR) Q1 Earnings Miss, View Impressive Zacks |
| 09:59AM | Allscripts (MDRX) Q1 Earnings & Revenues Lag, Bookings Rise Zacks |
| 09:19AM | DexCom (DXCM) Meets Q1 Earnings Estimates, Raises '18 View Zacks |
| May-03-18 01:36PM | Cardinal Health (CAH) Misses on Q3 Earnings, Lowers '18 View Zacks |
| 11:54AM | Genomic Health (GHDX) Q1 Earnings Top Estimates, Margins Low Zacks |
| 11:44AM | Cardiovascular Systems (CSII) Q3 Earnings Top, Revenues Meet Zacks |
| 10:31AM | Express Scripts (ESRX) Q1 Earnings Top, Patient Claims Fall Zacks |
| 10:22AM | Pacific Biosciences (PACB) Loss Wider Than Expected in Q1 Zacks |
| 10:21AM | Becton, Dickinson (BDX) Beats on Q2 Earnings, Lifts '18 View Zacks |
| 09:56AM | Hologic's (HOLX) Q2 Earnings Meet Estimates, Revenues Top Zacks |
| May-02-18 01:11PM | CVS Health's (CVS) Q1 Earnings Beat Estimate, Margins Grow Zacks |
| 11:00AM | AmerisourceBergen (ABC) Q2 Earnings Top, FY18 View Solid Zacks |
| 08:33AM | NuVasive (NUVA) Q1 Earnings Miss Estimates, Revenues In Line Zacks |
| 08:30AM | Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease Business Wire |
| May-01-18 09:49AM | Ecolab (ECL) Q1 Earnings & Revenues Top, '18 Guidance Solid Zacks |
| 09:05AM | Accuray (ARAY) Q3 Loss Wider Than Estimates, Revenues Top Zacks |
| 08:48AM | Inogen (INGN) Beats Q1 Earnings Estimates, Lifts 2018 View Zacks |
| 07:40AM | Blog Exposure - Hill-Rom Named John Groetelaars as President and CEO ACCESSWIRE |
| 06:53AM | PerkinElmer (PKI) Q1 Earnings & Revenues Top, '18 View Up Zacks |
| Apr-30-18 11:00AM | athenahealth (ATHN) Tops Earnings & Revenue Estimates in Q1 Zacks |
| 10:08AM | 3 Reasons Why You Should Invest in Baxter International Now Zacks |
| Apr-29-18 01:40PM | Edited Transcript of BAX earnings conference call or presentation 26-Apr-18 12:30pm GMT Thomson Reuters StreetEvents |
| Apr-26-18 03:03PM | Baxter International, Inc. Boosts Full-Year Outlook After Strong First Quarter Motley Fool +5.22% |
| 10:55AM | Baxter (BAX) Beats on Q1 Earnings & Revenues, Raises '18 View Zacks |
| 10:43AM | Earnings From LUV,CME,BAX And More Zacks |
| 10:28AM | Econ Data, Q1 Earnings Delivered in Bulk: CME, BAX, LUV & More Zacks |
| 09:04AM | Baxter (BAX) Beats on Q1 Earnings and Revenue Estimates Zacks |
| 07:22AM | Baxter: 1Q Earnings Snapshot Associated Press |
| 07:15AM | Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018 Business Wire |
| 06:55AM | Baxter International Inc. to Host Earnings Call ACCESSWIRE |
| Apr-25-18 06:50PM | Why Baxter International Inc (NYSE:BAX) Delivered An Inferior ROE Compared To The Industry Simply Wall St. |
| 04:43PM | Edwards CEO Mike Mussallem Driven By Passion For Helping Others Investor's Business Daily |
| 11:01AM | Medical Product Stock Earnings Roster for Apr 26: BAX & More Zacks |
| Apr-22-18 12:51AM | [$$] Allied Healthcare lines up rescue plan Financial Times |
| Apr-17-18 09:24AM | Can Hospital-Products Unit Aid Baxter (BAX) in Q1 Earnings? Zacks |
| Apr-16-18 08:26AM | Zacks.com highlights: Baxter International, Copart, Applied Materials and Steel Dynamics Zacks |
| Apr-13-18 09:06AM | 4 Top Stocks to Buy With Superb Efficiency Level Zacks |
| Apr-10-18 10:59AM | Edited Transcript of BAX presentation 7-Mar-17 12:30pm GMT Thomson Reuters StreetEvents |
| Apr-04-18 04:15PM | Baxter to Host First Quarter 2018 Financial Results Conference Call for Investors Business Wire |
| Apr-02-18 04:15PM | Baxter International Inc. to Host Webcast of Annual Meeting of Stockholders Business Wire |
| Mar-29-18 12:52PM | Baxter International Inc. -- Moody's upgrades Baxter International to Baa1 from Baa2, stable outlook Moody's |
| 11:35AM | Top Analyst Reports for Netflix, PNC Financial & Mondelez Zacks |
|
|
|
|
| Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Eyre Brik V | SVP, President, Americas | May 22 | Option Exercise | 37.38 | 25,000 | 934,500 | 90,115 | May 23 05:45 PM | | Shapazian Carole J | Director | May 22 | Option Exercise | 36.93 | 3,930 | 145,135 | 16,442 | May 23 05:33 PM | | Eyre Brik V | SVP, President, Americas | May 22 | Sale | 71.96 | 25,000 | 1,799,000 | 65,115 | May 23 05:45 PM | | Shapazian Carole J | Director | May 22 | Sale | 71.79 | 6,594 | 473,383 | 9,848 | May 23 05:33 PM | | Mason Jeanne K | SVP, Human Resources | May 21 | Option Exercise | 28.27 | 31,395 | 887,537 | 128,777 | May 23 05:43 PM | | Mason Jeanne K | SVP, Human Resources | May 21 | Sale | 72.00 | 31,395 | 2,260,440 | 97,382 | May 23 05:43 PM | | Eyre Brik V | SVP, President, Americas | May 15 | Option Exercise | 37.38 | 20,000 | 747,600 | 85,115 | May 17 04:03 PM | | Eyre Brik V | SVP, President, Americas | May 15 | Sale | 70.57 | 20,000 | 1,411,400 | 65,115 | May 17 04:03 PM | | STROUCKEN ALBERT P L | Director | Apr 02 | Option Exercise | 33.77 | 3,760 | 126,975 | 28,380 | Apr 04 05:21 PM | | HELLMAN PETER S | Director | Apr 02 | Option Exercise | 33.77 | 3,760 | 126,975 | 25,522 | Apr 04 05:21 PM | | HELLMAN PETER S | Director | Apr 02 | Sale | 64.74 | 3,760 | 243,408 | 21,762 | Apr 04 05:21 PM | | STROUCKEN ALBERT P L | Director | Apr 02 | Sale | 64.75 | 3,760 | 243,443 | 24,620 | Apr 04 05:21 PM | | STORM KORNELIS J. | Director | Mar 28 | Option Exercise | 34.49 | 47,959 | 1,654,198 | 70,471 | Mar 30 04:05 PM | | GAVIN JAMES R III | Director | Mar 28 | Option Exercise | 28.79 | 18,750 | 539,863 | 51,388 | Mar 30 04:03 PM | | STORM KORNELIS J. | Director | Mar 28 | Sale | 64.64 | 47,959 | 3,100,114 | 22,512 | Mar 30 04:05 PM | | GAVIN JAMES R III | Director | Mar 28 | Sale | 64.56 | 18,750 | 1,210,498 | 32,638 | Mar 30 04:03 PM | | Shapazian Carole J | Director | Mar 02 | Option Exercise | 31.26 | 4,990 | 155,987 | 14,838 | Mar 05 04:06 PM | | Shapazian Carole J | Director | Mar 02 | Sale | 66.05 | 4,990 | 329,590 | 9,848 | Mar 05 04:06 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Jan 02 | Option Exercise | 36.48 | 28,641 | 1,044,812 | 74,370 | Jan 03 04:15 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Jan 02 | Sale | 67.00 | 28,641 | 1,918,947 | 45,729 | Jan 03 04:15 PM | | Mason Jeanne K | SVP, Human Resources | Dec 04 | Option Exercise | 31.30 | 33,350 | 1,043,855 | 124,609 | Dec 06 04:02 PM | | Mason Jeanne K | SVP, Human Resources | Dec 04 | Sale | 65.25 | 33,350 | 2,176,088 | 91,259 | Dec 06 04:02 PM | | Third Point LLC | Director | Nov 06 | Sale | 64.23 | 5,000,000 | 321,150,000 | 36,001,790 | Nov 07 05:04 PM | | STALLKAMP THOMAS T | Director | Sep 05 | Option Exercise | 33.76 | 8,920 | 301,122 | 20,193 | Sep 06 05:46 PM | | STALLKAMP THOMAS T | Director | Sep 05 | Sale | 62.28 | 8,920 | 555,538 | 11,273 | Sep 06 05:46 PM | | FORSYTH JOHN D | Director | Aug 25 | Option Exercise | 29.56 | 9,440 | 279,086 | 38,124 | Aug 29 04:03 PM | | FORSYTH JOHN D | Director | Aug 25 | Sale | 61.76 | 9,440 | 583,014 | 28,684 | Aug 29 04:03 PM | | Shapazian Carole J | Director | Aug 24 | Option Exercise | 29.52 | 4,020 | 118,670 | 13,868 | Aug 25 04:02 PM | | Shapazian Carole J | Director | Aug 24 | Sale | 61.61 | 4,020 | 247,672 | 9,848 | Aug 25 04:02 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Aug 17 | Option Exercise | 37.38 | 12,670 | 473,605 | 33,286 | Aug 18 04:08 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Aug 17 | Sale | 60.96 | 12,670 | 772,363 | 20,616 | Aug 18 04:08 PM |
|
|
|
|
|
|
